Pediatric Asthma Treatment Market: Industry Analysis and forecast 2019 – 2027: By Application, Route of Administration, Distribution channel and Region.

Pediatric Asthma Treatment Market is expected to reach US$ 37.2 Bn. at a CAGR of 8.3 during the forecast period 2026. The report study has analyzed the revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers, and market disrupters in the report, and the same is reflected in our analysis. To know about the Research Methodology :- Request Free Sample Report Pediatric asthma is chronic inflammation of the airways identified by a hindrance of airflow. It is common chronic disease found in kids and newborn children and isn't easily detectable. The indications of pediatric asthma incorporate a whistling sound while breathing, quick and labored breathing, chest agony, coughing, and less energy or feeling of tiredness. As assessed by the World Health Organization (WHO), there were 383,000 deaths worldwide because of asthma. Presently, there are 235 million patients experiencing asthma globally. Pediatric asthma is not curable, but it may be prevented through regular checking, restricting smoking around youngsters, controlling heartburn, and other factors. The worldwide pediatric asthma treatment market is driven by growth in the incidence of asthma, increase in allergy cases, accessibility of advanced inhaler devices and innovative natural medications, and growing pollution levels. Likewise awareness about the diagnosis of asthma and growing health care facilities are probably going to drive the market. Advanced monitoring devices oversee pediatric asthma and help in controlling the condition. As assessed by the American Lung Association, the Centers for Disease Control and Prevention (CDC), and the National Institute of Allergy and Infectious Diseases (NIAID), 6 million kids are influenced by asthma as of now. Endorsements of new treatments are likewise a driving variable for the worldwide pediatric asthma treatment market. In any case, patent expiry of medications, increase in preference for generic drugs, and significant expense of pediatric asthma treatment are assessed to restrain the global pediatric asthma treatment market. Increase in mergers and acquisitions, joint efforts, and associations; increase in the popularity of combination therapies; and new product launches are assessed to offer speculation chances to organizations working in the global pediatric asthma treatment market. Notwithstanding the expanding prevalence of asthma worldwide including both, developing markets like Asia, and developed markets like North America, there are certain restraining elements that are restricting the adoption of these therapeutics. One of the main factor limiting the growth of the market is greater expenses related with asthma inhalers , which is frequently viewed as the essential treatment for Asthma. For example, the costs of Advair, a basic asthma drug has ascended from US$ 316 of every 2013 to US$ 496 out of 2018, archiving an expansion of 56.0%. Aside from the high drug costs, another basic factor has additionally restricted market development: the underdiagnosis of asthma. Under diagnosis of asthma prompts more unfortunate clinical results for the patient who can't receive the proper asthma drugs as a therapy for their medical condition. Such factors are foreseen to significantly restrain market development. North America, followed by Europe, has the biggest market for asthma treatment because of developed healthcare infrastructure, drug development and rise in aging populace. Moreover technological advancement for the treatment of asthma and ascend in asthma patients in this area are driving the North American asthma treatment market. Asia is relied upon to encounter high development rate in the asthma treatment market in next few years because of growing asthma patients, increasing disposable income, rise in environmental pollution, rising number of smokers and developing healthcare infrastructure in the region. The market size in North America was at USD 9.40 billion in 2019. Growing demographics and economies in the developing countries like India and China is expected to grow in asthma treatment market in Asia. The rest of the world market including of South America and the Middle East & Africa and is currently in the nascent stage. However, increasing prevalence of chronic respiratory diseases and growing launches of key products is projected to fuel the market demand in future. The objective of the report is to present a comprehensive analysis of the Pediatric Asthma Treatment Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Pediatric Asthma Treatment Market dynamics, structure by analyzing the market segments and projects the Pediatric Asthma Treatment Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Pediatric Asthma Treatment Market make the report investor’s guide.

Scope of the Global asthma treatment market: Inquire before buying

Global Asthma Treatment Market, By Product Type

• Long-Term Control Medications • Quick-Relief Medications

Global asthma treatment market, By Route of Administration

• Oral route route • Nasal route • Injectable route

Global asthma treatment market, By End User

• Hospitals • Clinics • Home Care • Others

Global asthma treatment market, By Region

• Asia Pacific • North America • Europe • South America • Middle East & Africa

Key players operating in the Global asthma treatment market

• AstraZeneca, • Merck & Co., • Chiesi Farmaceutici, • GlaxoSmithKline, • Novartis AG and F. • Hoffmann-La Roche • Cipla,, • Dr. Reddy’s Laboratories, • Actavis, Orchid Chemicals and Pharmaceuticals, • Abbott • Boehringer Ingelheim • Regeneron Pharmaceuticals • Pfizer • Teva Pharmaceuticals • Mylan N.V. • International GmbH • Regeneron • Sano Genentech, Inc. • Sumitomo Dainippon Pharma Co., Ltd. • Others
Pediatric Asthma Treatment Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Asthma Treatment Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Asthma Treatment Market Analysis and Forecast 6.1. Global Asthma Treatment Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Asthma Treatment Market Analysis and Forecast, By Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Asthma Treatment Market Value Share Analysis, By Product 7.4. Global Asthma Treatment Market Size (US$ Bn) Forecast, By Product 7.5. Global Asthma Treatment Market Analysis, By Product 8. Global Asthma Treatment Market Analysis and Forecast, By Route of Administration 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Asthma Treatment Market Value Share Analysis, By Route of Administration 8.4. Global Asthma Treatment Market Size (US$ Bn) Forecast, By Route of Administration 8.5. Global Asthma Treatment Market Analysis, By Route of Administration 8.6. Global Asthma Treatment Market Attractiveness Analysis, By Route of Administration 9. Global Asthma Treatment Market Analysis and Forecast, By End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Global Asthma Treatment Market Value Share Analysis, By End User 9.4. Global Asthma Treatment Market Size (US$ Bn) Forecast, By End User 9.5. Global Asthma Treatment Market Analysis, By End User 10. Global Asthma Treatment Market Analysis, by Region 10.1. Global Asthma Treatment Market Value Share Analysis, by Region 10.2. Global Asthma Treatment Market Size (US$ Bn) Forecast, by Region 10.3. Global Asthma Treatment Market Attractiveness Analysis, By Region 11. North America Global Asthma Treatment Market Analysis 11.1. Key Findings 11.2. North America Global Asthma Treatment Market Overview 11.3. North America Global Asthma Treatment Market Value Share Analysis, By Product 11.4. North America Global Asthma Treatment Market Forecast, By Product 11.4.1. Long-Term Control Medications 11.4.2. Quick-Relief Medications 11.4.3. Others 11.5. North America Global Asthma Treatment Market Value Share Analysis, By Route of Administration 11.6. North America Global Asthma Treatment Market Forecast, By Route of Administration 11.6.1. Oral route 11.6.2. Others(Nasal route,Injectable route) 11.7. North America Global Asthma Treatment Market Value Share Analysis, By End User 11.8. North America Global Asthma Treatment Market Forecast, By End User 11.8.1. Hospitals 11.8.2. Clinics 11.8.3. Home care 11.8.4. Others 11.9. North America Global Asthma Treatment Market Value Share Analysis, by Country 11.9.1. U.S. 11.9.2. Canada 11.10. U.S. Global Asthma Treatment Market Value Share Analysis, By Product 11.11. U.S. Global Asthma Treatment Market Forecast, By Product 11.11.1. Long-Term Control Medications 11.11.2. Quick-Relief Medications 11.11.3. Others 11.12. U.S. Global Asthma Treatment Market Value Share Analysis, By Route of Administration 11.13. U.S. Global Asthma Treatment Market Forecast, By Route of Administration 11.13.1. Oral route 11.13.2. Others(Nasal route, Injectable route) 11.14. U.S. Global Asthma Treatment Market Value Share Analysis, By End User 11.15. U.S. Global Asthma Treatment Market Forecast, By End User 11.15.1. Hospitals 11.15.2. Clinics 11.15.3. Home care 11.15.4. Others 11.16. Canada Global Asthma Treatment Market Value Share Analysis, By Product 11.17. Canada Global Asthma Treatment Market Forecast, By Product 11.17.1. Long-Term Control Medications 11.17.2. Quick-Relief Medications 11.17.3. Others 11.18. Canada Global Asthma Treatment Market Value Share Analysis, By Route of Administration 11.19. Canada Global Asthma Treatment Market Forecast, By Route of Administration 11.19.1. Oral route 11.19.2. Others(Nasal route,Injectable route) 11.20. Canada Global Asthma Treatment Market Value Share Analysis, By End User 11.21. Canada Global Asthma Treatment Market Forecast, By End User 11.21.1. Hospitals 11.21.2. Clinics 11.21.3. Home care 11.21.4. Others 11.22. PEST Analysis 11.23. Key Trends 11.24. Key Developments 12. Europe Global Asthma Treatment Market Analysis 12.1. Key Findings 12.2. Europe Global Asthma Treatment Market Overview 12.3. Europe Global Asthma Treatment Market Value Share Analysis, By Product 12.4. Europe Global Asthma Treatment Market Forecast, By Product 12.4.1. Long-Term Control Medications 12.4.2. Quick-Relief Medications 12.4.3. Others 12.5. Europe Global Asthma Treatment Market Value Share Analysis, By Route of Administration 12.6. Europe Global Asthma Treatment Market Forecast, By Route of Administration 12.6.1. Oral route 12.6.2. Others(Nasal route,Injectable route) 12.7. Europe Global Asthma Treatment Market Value Share Analysis, By End User 12.8. Europe Global Asthma Treatment Market Forecast, By End User 12.8.1. Hospitals 12.8.2. Clinics 12.8.3. Home care 12.8.4. Others 12.9. Europe Global Asthma Treatment Market Value Share Analysis, by Country 12.9.1. U.K. 12.9.2. Germany 12.9.3. France 12.9.4. Italy 12.9.5. Spain 12.9.6. Rest of Europe 12.10. U.K. Global Asthma Treatment Market Value Share Analysis, By Product 12.11. U.K. Global Asthma Treatment Market Forecast, By Product 12.11.1. Long-Term Control Medications 12.11.2. Quick-Relief Medications 12.11.3. Others 12.12. U.K. Global Asthma Treatment Market Value Share Analysis, By Route of Administration 12.13. U.K. Global Asthma Treatment Market Forecast, By Route of Administration 12.13.1. Oral route 12.13.2. Others(Nasal route,Injectable route) 12.14. U.K. Global Asthma Treatment Market Value Share Analysis, By End User 12.15. U.K. Global Asthma Treatment Market Forecast, By End User 12.15.1. Hospitals 12.15.2. Clinics 12.15.3. Home care 12.15.4. Others 12.16. Germany Global Asthma Treatment Market Value Share Analysis, By Product 12.17. Germany Global Asthma Treatment Market Forecast, By Product 12.17.1. Long-Term Control Medications 12.17.2. Quick-Relief Medications 12.17.3. Others 12.18. Germany Global Asthma Treatment Market Value Share Analysis, By Route of Administration 12.19. Germany Global Asthma Treatment Market Forecast, By Route of Administration 12.19.1. Oral route 12.19.2. Others(Nasal route,Injectable route) 12.20. Germany Global Asthma Treatment Market Value Share Analysis, By End User 12.21. Germany Global Asthma Treatment Market Forecast, By End User 12.21.1. Hospitals 12.21.2. Clinics 12.21.3. Home care 12.21.4. Others 12.22. France Global Asthma Treatment Market Value Share Analysis, By Product 12.23. France Global Asthma Treatment Market Forecast, By Product 12.23.1. Long-Term Control Medications 12.23.2. Quick-Relief Medications 12.23.3. Others 12.24. France Global Asthma Treatment Market Value Share Analysis, By Route of Administration 12.25. France Global Asthma Treatment Market Forecast, By Route of Administration 12.25.1. Oral route 12.25.2. Others(Nasal route,Injectable route) 12.26. France Global Asthma Treatment Market Value Share Analysis, By End User 12.27. France Global Asthma Treatment Market Forecast, By End User 12.27.1. Hospitals 12.27.2. Clinics 12.27.3. Home care 12.27.4. Others 12.28. Italy Global Asthma Treatment Market Value Share Analysis, By Product 12.29. Italy Global Asthma Treatment Market Forecast, By Product 12.29.1. Long-Term Control Medications 12.29.2. Quick-Relief Medications 12.29.3. Others 12.30. Italy Global Asthma Treatment Market Value Share Analysis, By Route of Administration 12.31. Italy Global Asthma Treatment Market Forecast, By Route of Administration 12.31.1. Oral route 12.31.2. Others(Nasal route,Injectable route) 12.32. Italy Global Asthma Treatment Market Value Share Analysis, By End User 12.33. Italy Global Asthma Treatment Market Forecast, By End User 12.33.1. Hospitals 12.33.2. Clinics 12.33.3. Home care 12.33.4. Others 12.34. Spain Global Asthma Treatment Market Value Share Analysis, By Product 12.35. Spain Global Asthma Treatment Market Forecast, By Product 12.35.1. Long-Term Control Medications 12.35.2. Quick-Relief Medications 12.35.3. Others 12.36. Spain Global Asthma Treatment Market Value Share Analysis, By Route of Administration 12.37. Spain Global Asthma Treatment Market Forecast, By Route of Administration 12.37.1. Oral route 12.37.2. Others(Nasal route,Injectable route) 12.38. Spain Global Asthma Treatment Market Value Share Analysis, By End User 12.39. Spain Global Asthma Treatment Market Forecast, By End User 12.39.1. Hospitals 12.39.2. Clinics 12.39.3. Home care 12.39.4. Others 12.40. Rest of Europe Global Asthma Treatment Market Value Share Analysis, By Product 12.41. Rest of Europe Global Asthma Treatment Market Forecast, By Product 12.41.1. Long-Term Control Medications 12.41.2. Quick-Relief Medications 12.41.3. Others 12.42. Rest of Europe Global Asthma Treatment Market Value Share Analysis, By Route of Administration 12.43. Rest of Europe Global Asthma Treatment Market Forecast, By Route of Administration 12.43.1. Oral route 12.43.2. Others(Nasal route,Injectable route) 12.44. Rest of Europe Global Asthma Treatment Market Value Share Analysis, By End User 12.45. Rest of Europe Global Asthma Treatment Market Forecast, By End User 12.45.1. Hospitals 12.45.2. Clinics 12.45.3. Home care 12.45.4. Others 12.46. PEST Analysis 12.47. Key Trends 12.48. Key Developments 13. Asia Pacific Global Asthma Treatment Market Analysis 13.1. Key Findings 13.2. Asia Pacific Global Asthma Treatment Market Overview 13.3. Asia Pacific Global Asthma Treatment Market Value Share Analysis, By Product 13.4. Asia Pacific Global Asthma Treatment Market Forecast, By Product 13.4.1. Long-Term Control Medications 13.4.2. Quick-Relief Medications 13.4.3. Others 13.5. Asia Pacific Global Asthma Treatment Market Value Share Analysis, By Route of Administration 13.6. Asia Pacific Global Asthma Treatment Market Forecast, By Route of Administration 13.6.1. Oral route 13.6.2. Others(Nasal route,Injectable route) 13.7. Asia Pacific Global Asthma Treatment Market Value Share Analysis, By End User 13.8. Asia Pacific Global Asthma Treatment Market Forecast, By End User 13.8.1. Hospitals 13.8.2. Clinics 13.8.3. Home care 13.8.4. Others 13.9. Asia Pacific Global Asthma Treatment Market Value Share Analysis, by Country 13.9.1. China 13.9.2. India 13.9.3. Japan 13.9.4. ASEAN 13.9.5. Rest of Asia Pacific 13.10. China Global Asthma Treatment Market Value Share Analysis, By Product 13.11. China Global Asthma Treatment Market Forecast, By Product 13.11.1. Long-Term Control Medications 13.11.2. Quick-Relief Medications 13.11.3. Others 13.12. China Global Asthma Treatment Market Value Share Analysis, By Route of Administration 13.13. China Global Asthma Treatment Market Forecast, By Route of Administration 13.13.1. Oral route 13.13.2. Others(Nasal route, Injectable route) 13.14. China Global Asthma Treatment Market Value Share Analysis, By End User 13.15. China Global Asthma Treatment Market Forecast, By End User 13.15.1. Hospitals 13.15.2. Clinics 13.15.3. Home care 13.15.4. Others 13.16. India Global Asthma Treatment Market Value Share Analysis, By Product 13.17. India Global Asthma Treatment Market Forecast, By Product 13.17.1. Long-Term Control Medications 13.17.2. Quick-Relief Medications 13.17.3. Others 13.18. India Global Asthma Treatment Market Value Share Analysis, By Route of Administration 13.19. India Global Asthma Treatment Market Forecast, By Route of Administration 13.19.1. Oral route 13.19.2. Others(Nasal route, Injectable route) 13.20. India Global Asthma Treatment Market Value Share Analysis, By End User 13.21. India Global Asthma Treatment Market Forecast, By End User 13.21.1. Hospitals 13.21.2. Clinics 13.21.3. Home care 13.21.4. Others 13.22. Japan Global Asthma Treatment Market Value Share Analysis, By Product 13.23. Japan Global Asthma Treatment Market Forecast, By Product 13.23.1. Long-Term Control Medications 13.23.2. Quick-Relief Medications 13.23.3. Others 13.24. Japan Global Asthma Treatment Market Value Share Analysis, By Route of Administration 13.25. Japan Global Asthma Treatment Market Forecast, By Route of Administration 13.25.1. Oral route 13.25.2. Others(Nasal route, Injectable route) 13.26. Japan Global Asthma Treatment Market Value Share Analysis, By End User 13.27. Japan Global Asthma Treatment Market Forecast, By End User 13.27.1. Hospitals 13.27.2. Clinics 13.27.3. Home care 13.27.4. Others 13.28. ASEAN Global Asthma Treatment Market Value Share Analysis, By Product 13.29. ASEAN Global Asthma Treatment Market Forecast, By Product 13.29.1. Long-Term Control Medications 13.29.2. Quick-Relief Medications 13.29.3. Others 13.30. ASEAN Global Asthma Treatment Market Value Share Analysis, By Route of Administration 13.31. ASEAN Global Asthma Treatment Market Forecast, By Route of Administration 13.31.1. Oral route 13.31.2. Others(Nasal route, Injectable route) 13.32. ASEAN Global Asthma Treatment Market Value Share Analysis, By End User 13.33. ASEAN Global Asthma Treatment Market Forecast, By End User 13.33.1. Hospitals 13.33.2. Clinics 13.33.3. Home care 13.33.4. Others 13.34. Rest of Asia Pacific Global Asthma Treatment Market Value Share Analysis, By Product 13.35. Rest of Asia Pacific Global Asthma Treatment Market Forecast, By Product 13.35.1. Long-Term Control Medications 13.35.2. Quick-Relief Medications 13.35.3. Others 13.36. Rest of Asia Pacific Global Asthma Treatment Market Value Share Analysis, By Route of Administration 13.37. Rest of Asia Pacific Global Asthma Treatment Market Forecast, By Route of Administration 13.37.1. Oral route 13.37.2. Others(Nasal route, Injectable route) 13.38. Rest of Asia Pacific Global Asthma Treatment Market Value Share Analysis, By End User 13.39. Rest of Asia Pacific Global Asthma Treatment Market Forecast, By End User 13.39.1. Hospitals 13.39.2. Clinics 13.39.3. Home care 13.39.4. Others 13.40. PEST Analysis 13.41. Key Trends 13.42. Key Developments 14. Middle East and Africa Global Asthma Treatment Market Analysis 14.1. Key Findings 14.2. Middle East and Africa Global Asthma Treatment Market Overview 14.3. Middle East and Africa Global Asthma Treatment Market Value Share Analysis, By Product 14.4. Middle East and Africa Global Asthma Treatment Market Forecast, By Product 14.4.1. Long-Term Control Medications 14.4.2. Quick-Relief Medications 14.4.3. Others 14.5. Middle East and Africa Global Asthma Treatment Market Value Share Analysis, By Route of Administration 14.6. Middle East and Africa Global Asthma Treatment Market Forecast, By Route of Administration 14.6.1. Oral route 14.6.2. Others(Nasal route, Injectable route) 14.7. Middle East and Africa Global Asthma Treatment Market Value Share Analysis, By End User 14.8. Middle East and Africa Global Asthma Treatment Market Forecast, By End User 14.8.1. Hospitals 14.8.2. Clinics 14.8.3. Home care 14.8.4. Others 14.9. Middle East and Africa Global Asthma Treatment Market Value Share Analysis, by Country 14.9.1. South Africa 14.9.2. GCC 14.9.3. Rest of Middle East and Africa 14.10. GCC Global Asthma Treatment Market Value Share Analysis, By Product 14.11. GCC Global Asthma Treatment Market Forecast, By Product 14.11.1. Long-Term Control Medications 14.11.2. Quick-Relief Medications 14.11.3. Others 14.12. GCC Global Asthma Treatment Market Value Share Analysis, By Route of Administration 14.13. GCC Global Asthma Treatment Market Forecast, By Route of Administration 14.13.1. Oral route 14.13.2. Others(Nasal route, Injectable route) 14.14. GCC Global Asthma Treatment Market Value Share Analysis, By End User 14.15. GCC Global Asthma Treatment Market Forecast, By End User 14.15.1. Hospitals 14.15.2. Clinics 14.15.3. Home care 14.15.4. Others 14.16. South Africa Global Asthma Treatment Market Value Share Analysis, By Product 14.17. South Africa Global Asthma Treatment Market Forecast, By Product 14.17.1. Long-Term Control Medications 14.17.2. Quick-Relief Medications 14.17.3. Others 14.18. South Africa Global Asthma Treatment Market Value Share Analysis, By Route of Administration 14.19. South Africa Global Asthma Treatment Market Forecast, By Route of Administration 14.19.1. Oral route 14.19.2. Others(Nasal route, Injectable route) 14.20. South Africa Global Asthma Treatment Market Value Share Analysis, By End User 14.21. South Africa Global Asthma Treatment Market Forecast, By End User 14.21.1. Hospitals 14.21.2. Clinics 14.21.3. Home care 14.21.4. Others 14.22. Rest of Middle East and Africa Global Asthma Treatment Market Value Share Analysis, By Product 14.23. Rest of Middle East and Africa Global Asthma Treatment Market Forecast, By Product 14.23.1. Long-Term Control Medications 14.23.2. Quick-Relief Medications 14.23.3. Others 14.24. Rest of Middle East and Africa Global Asthma Treatment Market Value Share Analysis, By Route of Administration 14.25. Rest of Middle East and Africa Global Asthma Treatment Market Forecast, By Route of Administration 14.25.1. Oral route 14.25.2. Others(Nasal route, Injectable route) 14.26. Rest of Middle East and Africa Global Asthma Treatment Market Value Share Analysis, By End User 14.27. Rest of Middle East and Africa Global Asthma Treatment Market Forecast, By End User 14.27.1. Hospitals 14.27.2. Clinics 14.27.3. Home care 14.27.4. Others 14.28. PEST Analysis 14.29. Key Trends 14.30. Key Developments 15. South America Global Asthma Treatment Market Analysis 15.1. Key Findings 15.2. South America Global Asthma Treatment Market Overview 15.3. South America Global Asthma Treatment Market Value Share Analysis, By Product 15.4. South America Global Asthma Treatment Market Forecast, By Product 15.4.1. Long-Term Control Medications 15.4.2. Quick-Relief Medications 15.4.3. Others 15.5. South America Global Asthma Treatment Market Value Share Analysis, By Route of Administration 15.6. South America Global Asthma Treatment Market Forecast, By Route of Administration 15.6.1. Oral route 15.6.2. Others(Nasal route, Injectable route) 15.7. South America Global Asthma Treatment Market Value Share Analysis, By End User 15.8. South America Global Asthma Treatment Market Forecast, By End User 15.8.1. Hospitals 15.8.2. Clinics 15.8.3. Home care 15.8.4. Others 15.9. South America Global Asthma Treatment Market Value Share Analysis, by Country 15.9.1. Mexico 15.9.2. Brazil 15.9.3. Rest of South America 15.10. Mexico Global Asthma Treatment Market Value Share Analysis, By Product 15.11. Mexico Global Asthma Treatment Market Forecast, By Product 15.11.1. Long-Term Control Medications 15.11.2. Quick-Relief Medications 15.11.3. Others 15.12. Mexico Global Asthma Treatment Market Value Share Analysis, By Route of Administration 15.13. Mexico Global Asthma Treatment Market Forecast, By Route of Administration 15.13.1. Oral route 15.13.2. Others(Nasal route,Injectable route) 15.14. Mexico Global Asthma Treatment Market Value Share Analysis, By End User 15.15. Mexico Global Asthma Treatment Market Forecast, By End User 15.15.1. Hospitals 15.15.2. Clinics 15.15.3. Home care 15.15.4. Others 15.16. Brazil Global Asthma Treatment Market Value Share Analysis, By Product 15.17. Brazil Global Asthma Treatment Market Forecast, By Product 15.17.1. Long-Term Control Medications 15.17.2. Quick-Relief Medications 15.17.3. Others 15.18. Brazil Global Asthma Treatment Market Value Share Analysis, By Route of Administration 15.19. Brazil Global Asthma Treatment Market Forecast, By Route of Administration 15.19.1. Oral route 15.19.2. Others(Nasal route,Injectable route) 15.20. Brazil Global Asthma Treatment Market Value Share Analysis, By End User 15.21. Brazil Global Asthma Treatment Market Forecast, By End User 15.21.1. Hospitals 15.21.2. Clinics 15.21.3. Home care 15.21.4. Others 15.22. Rest of South America Global Asthma Treatment Market Value Share Analysis, By Product 15.23. Rest of South America Global Asthma Treatment Market Forecast, By Product 15.23.1. Long-Term Control Medications 15.23.2. Quick-Relief Medications 15.23.3. Others 15.24. Rest of South America Global Asthma Treatment Market Value Share Analysis, By Route of Administration 15.25. Rest of South America Global Asthma Treatment Market Forecast, By Route of Administration 15.25.1. Oral route 15.25.2. Others(Nasal route,Injectable route) 15.26. Rest of South America Global Asthma Treatment Market Value Share Analysis, By End User 15.27. Rest of South America Global Asthma Treatment Market Forecast, By End User 15.27.1. Hospitals 15.27.2. Clinics 15.27.3. Home care 15.27.4. Others 15.28. PEST Analysis 15.29. Key Trends 15.30. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Pfizer 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. AstraZeneca, 16.3.3. Merck & Co., 16.3.4. Chiesi Farmaceutici, 16.3.5. GlaxoSmithKline, 16.3.6. Novartis AG and F. 16.3.7. Hoffmann-La Roche 16.3.8. Cipla,, 16.3.9. Dr. Reddy’s Laboratories, 16.3.10. Actavis, 16.3.11. Orchid Chemicals and Pharmaceuticals, 16.3.12. Abbott 16.3.13. Boehringer Ingelheim 16.3.14. Regeneron Pharmaceuticals 16.3.15. Teva Pharmaceuticals 16.3.16. Mylan N.V. 16.3.17. International GmbH 16.3.18. Regeneron 16.3.19. Sano Genentech, Inc. 16.3.20. Sumitomo Dainippon Pharma Co., Ltd. 16.3.21. Others

About This Report

Report ID 75734
Category Healthcare
Published Date Oct 2020
Updated Date
Contact Us